What is the role of CBAC in the Nonuse, Nondisclosure and Non-Competition Agreement with Christian Brothers Automotive?
Christian_Brothers_Automotive Franchise · 2025 FDDAnswer from 2025 FDD Document
EEMENT
| This Nonuse, Nondisclosure and Non-Competition Agreement (the "Agreement") is | |
|---|---|
| entered into by and among, whose | |
| address is,,, (collectively | |
| together with all affiliates, representatives and agents collectively referred to as "Franchisee | |
| Candidate") and CHRISTIAN BROTHERS AUTOMOTIVE CORPORATION, a Texas | |
| corporation, whose address is 17725 Katy Freeway, Houston, Texas 77094 ("CBAC"). |
Source: Item 22 — CONTRACTS (FDD page 76)
What This Means (2025 FDD)
According to the 2025 Christian Brothers Automotive Franchise Disclosure Document, Christian Brothers Automotive Corporation, a Texas corporation, also referred to as "CBAC", is one of the parties entering into the Nonuse, Nondisclosure, and Non-Competition Agreement. The other party is the "Franchisee Candidate," which includes the individual or entity seeking to become a franchisee, along with their affiliates, representatives, and agents. CBAC's address is 17725 Katy Freeway, Houston, Texas 77094.
This agreement is a standard legal document used in franchising to protect the franchisor's confidential information, trade secrets, and business methods. It prevents potential franchisees from using this information to compete with Christian Brothers Automotive, whether or not they ultimately become franchisees. The agreement ensures that sensitive business data remains protected.
Prospective franchisees should carefully review the terms of the Nonuse, Nondisclosure, and Non-Competition Agreement with their legal counsel to understand the full scope of their obligations. This includes understanding the duration of the non-compete period, the geographic area covered, and the types of activities that are restricted. Understanding these details is crucial before entering into a franchise agreement with Christian Brothers Automotive.